Tag: niddk
-
NIH Researchers Identify Pathway to Enhance GLP-1 Weight Loss Effects
NIH scientists have identified key intracellular signaling pathways in neurons that influence GLP-1 drug semaglutide's weight-loss effects. Modulating these pathways, particularly cAMP levels, could lead to more sustained and effective treatments for obesity.
HealthScience & TechnologyPolitics and GovernmentMedical ScienceFederal Government NIHGLP-1SemaglutideWeight LosscAMPNIDDKRoflumilastNational Institutes of Health